Stock Events

Stock Events

Myomo 

$1.6800
80
+$0.11+7.01% Tuesday 19:59
-$0.06-3.48%Tuesday 23:54After hours

Statistics

Day High
1.695
Day Low
1.675
52W High
1.8
52W Low
0.605
Volume
30,099
Avg. Volume
-
Mkt Cap
66.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.11
-0.08
-0.04
-0.01
Expected EPS
-0.08
Actual EPS
N/A

Financials

-38.05%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
40.93MRevenue
-15.57MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYO. It's not an investment recommendation.
NVIDIA
16
NVDA
Microsoft
14
MSFT
Amazon
13
AMZN
Apple
12
AAPL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Resmed
RMD
Mkt Cap32.38B
ResMed is known for its products in the sleep and respiratory markets but also offers devices that can improve quality of life, indirectly competing with Myomo's focus on enhancing mobility.
Smith & Nephew
SNN
Mkt Cap12.48B
Smith & Nephew specializes in orthopedics, including robotics and digital solutions for surgery, which can indirectly compete with Myomo's orthotic devices by offering alternative treatments and rehabilitation methods.
Zimmer Biomet
ZBH
Mkt Cap19.2B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, including products for joint reconstruction which can indirectly compete with Myomo's solutions for mobility and rehabilitation.
Medtronic
MDT
Mkt Cap116.83B
Medtronic plc offers a wide range of medical devices and therapies, including those for spinal and musculoskeletal conditions, indirectly competing with Myomo's assistive technologies.
Stryker
SYK
Mkt Cap130.11B
Stryker Corporation specializes in medical and surgical equipment, including neurotechnology and spine products, which can indirectly compete with Myomo's focus on enhancing mobility through technology.
Globus Medical
GMED
Mkt Cap11.53B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic devices, indirectly competing with Myomo by offering alternative treatments for mobility impairments.

About

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Show more...
CEO
Paul R. Gudonis
Employees
195
Country
United States
ISIN
US62857J2015
WKN
000A2PZCL

Listings

STU
DE
0M61.STU
MU
DE
0M61.MU
STU
DE
0M6.STU
F
DE
0M61.F

0 Comments

Share your thoughts

FAQ

What is Myomo stock price today?▼
The current price of MYO is $1.68 USD — it has increased by +7.01% in the past 24 hours. Watch Myomo stock price performance more closely on the chart.
What is Myomo stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XASE exchange Myomo stocks are traded under the ticker MYO.
Is Myomo stock price growing?▼
MYO stock has risen by +10.53% compared to the previous week, the month change is a +76.82% rise, over the last year Myomo has showed a +47.37% increase.
What is Myomo market cap?▼
Today Myomo has the market capitalization of 66.54M
When is the next Myomo earnings date?▼
Myomo is going to release the next earnings report on November 11, 2026.
What were Myomo earnings last quarter?▼
MYO earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.1 USD resulting in a +8.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Myomo revenue for the last year?▼
Myomo revenue for the last year amounts to 40.93M USD.
What is Myomo net income for the last year?▼
MYO net income for the last year is -15.57M USD.
How many employees does Myomo have?▼
As of August 19, 2026, the company has 195 employees.
In which sector is Myomo located?▼
Myomo operates in the Health & Wellness sector.
When did Myomo complete a stock split?▼
The last stock split for Myomo was on January 31, 2020 with a ratio of 1:30.
Where is Myomo headquartered?▼
Myomo is headquartered in BOSTON, United States.